Jump to content
Register now for free to get your favorite username before it is gone! ×
  • entries
    360
  • comments
    6
  • views
    14,388

Entries in this blog

Spinal Muscular Atrophy Market

The Spinal Muscular Atrophy Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Muscular Dystrophy

Spinal muscular atrophy (SMA) is a genetic disease that affects the nervous system and muscle strength. It is caused by deficiency of Survival Motor Neuron (SMN) protein due to deletions or mutations in the SMN1 gene. There are different types of SMA classified based on the age of onset and highest physical milestone achieved. SMA treatments include nusinersen and risdiplam that address the underlying genetic root cause of SMA. The global spinal muscular atrophy market is estimated to be va


×
×
  • Create New...

Important Information

Please review our Terms of Use and Privacy Policy before using this site., We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.